Date: 2017-02-15
Type of information: Nomination
Compound:
Company: Avexis (USA - IL)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details:
- On February 15, 2017, AveXis announced the appointment of Rick Modi to the executive management team as Senior Vice President and Chief Business Officer. Mr. Modi brings more than 15 years of commercial, business, and corporate experience to the position, and is responsible for all aspects of the company’s commercial functions. Modi reports to Sean Nolan, President and Chief Executive Officer of AveXis.
- Prior to AveXis, Rick Modi held roles of increasing responsibilities in sales, marketing, access and corporate strategy at Centocor (Johnson & Johnson), Medimmune (AstraZeneca) and InterMune (Roche), where he played leadership roles in product launches in multiple different specialty and rare disease indications. Most recently, Mr. Modi served as Chief Business Officer at Catabasis Pharmaceuticals.
- Mr. Modi earned a BS degree in Pharmacy from the University of Iowa and an MBA from the Wharton School.
Financial terms:
Latest news:
Is general: Yes
